ALA 1.61% 15.3¢ arovella therapeutics limited

Ann: Becoming a substantial holder RM, page-13

  1. 7,256 Posts.
    lightbulb Created with Sketch. 283
    @Bluebush , i wasn't able to find the interview where Baker talked about M&A , but he did mention it again in yesterday's ****** interview (fr 3:45).

    "Large pharmas are willing to engage in therapy like this in preclinical stage ... "

    *** aus b1z**
    Last edited by abitlikeme: 28/06/23
 
watchlist Created with Sketch. Add ALA (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.